GeneFerm Biotechnology Co., Ltd.
1796.TWO
Price:
$46.8
Market Cap:
$1.94B
GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health care products in Taiwan and internationally. The company offers microbial fermentation products, which includes mushrooms, lactic acid bacteria, bacteria, yeast, and algae; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, fruits and vegetables fermented enzyme, as well as probiotics and peptide ingredients. It also provides private label supplements; packaging equipment; microbial fermentation toll manufactu...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2016-07-26
Stock Exchange
TWO
Ticker
1796.TWO
PE Ratio
[120.00]
ROE
[-0.10%]
Current Ratio
[4.03]
Dividend Yield
[0%]
Enterprise Value
[2.04B]
Dividend History
The PE Ratio as of December 2025 (TTM) for GeneFerm Biotechnology Co., Ltd. (1796.TWO) is 120.00
According to GeneFerm Biotechnology Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 120.00. This represents a change of -35.30% compared to the average of 185.48 of the last 4 quarters.
GeneFerm Biotechnology Co., Ltd. (1796.TWO) Historical PE Ratio (quarterly & annually)
How has 1796.TWO PE Ratio performed in the past?
The mean historical PE Ratio of GeneFerm Biotechnology Co., Ltd. over the last ten years is 24.46. The current 120.00 PE Ratio has changed 48.96% with respect to the historical average. Over the past ten years (40 quarters), 1796.TWO's PE Ratio was at its highest in in the June 2025 quarter at 550.00. The PE Ratio was at its lowest in in the June 2024 quarter at -107.67.
Average
24.46
Median
27.16
Minimum
-86.50
Maximum
179.22
GeneFerm Biotechnology Co., Ltd. (1796.TWO) PE Ratio by Quarter and Year
Discovering the peaks and valleys of GeneFerm Biotechnology Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 179.22
Minimum Annual Increase = -679.29%
Minimum Annual PE Ratio = -86.50
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -86.50 | -449.94% |
| 2023 | 24.72 | -16.49% |
| 2022 | 29.60 | -3.43% |
| 2021 | 30.65 | -82.90% |
| 2020 | 179.22 | -679.29% |
GeneFerm Biotechnology Co., Ltd. (1796.TWO) Average PE Ratio
How has 1796.TWO PE Ratio performed in the past?
The current PE Ratio of GeneFerm Biotechnology Co., Ltd. (1796.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.73
5-year avg
35.54
10-year avg
24.46
GeneFerm Biotechnology Co., Ltd. (1796.TWO) PE Ratio vs. Peers
How is 1796.TWO’s PE Ratio compared to its peers?
GeneFerm Biotechnology Co., Ltd.’s PE Ratio is greater than LIWANLI Innovation Co., Ltd. (-78.49), greater than Winston Medical Supply Co., Ltd. (12.77), greater than TSH Biopharm Corporation Limited (18.67), greater than InnoPharmax Inc. (-21.12), greater than Golden Biotechnology Corporation (-15.69), greater than Allied Biotech Corporation (-41.90), greater than Crystalvue Medical Corporation (14.50), greater than Sunny Pharmtech Inc. (-7.79), greater than BenQ Medical Technology Corporation (23.49), greater than OK Biotech Co., Ltd. (-53.85),
| Company | PE Ratio | Market cap |
|---|---|---|
| -78.49 | $1.91B | |
| 12.77 | $1.71B | |
| 18.67 | $2.13B | |
| -21.12 | $2.28B | |
| -15.69 | $5.56B | |
| -41.90 | $2.36B | |
| 14.50 | $2.01B | |
| -7.79 | $2.10B | |
| 23.49 | $2.01B | |
| -53.85 | $2.22B |
Build a custom stock screener for GeneFerm Biotechnology Co., Ltd. (1796.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeneFerm Biotechnology Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
GeneFerm Biotechnology Co., Ltd. (1796.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like GeneFerm Biotechnology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is GeneFerm Biotechnology Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for GeneFerm Biotechnology Co., Ltd. (1796.TWO)?
What is the highest PE Ratio for GeneFerm Biotechnology Co., Ltd. (1796.TWO)?
What is the 3-year average PE Ratio for GeneFerm Biotechnology Co., Ltd. (1796.TWO)?
What is the 5-year average PE Ratio for GeneFerm Biotechnology Co., Ltd. (1796.TWO)?
How does the current PE Ratio for GeneFerm Biotechnology Co., Ltd. (1796.TWO) compare to its historical average?